Isolating endothelial cells from tumors in the rhoB−/− and rhoB+/+ mice, showed a dose-dependent decrease in p-AKT associated with allelic loss, supporting the idea that RhoB may play competing biological roles in tumor versus endothelial cells. This evidence concerns the gene RHOB and neoplasm.